Cancer is one of the most deadly and common disease in the world right now. This disease comes in many different figures and forms. One common type of cancer is the colon cancer. Colon cancer consists of many different types, yet the bright side is that they are all curable.
However, the bad part of colon cancer is the fact that the current technology available to detect the disease in the human body is not well developed. This consists of wrongful imagining devices that may not detect the disease, thus making it reach more critical levels.
This problem has inspired engineers to be able to develop a new imaging device that can well detect the cancer without informalities. This is the case for blood based cancer where the blood cells can form a barrier, disallowing imaging devices to detect the disease.
The study and results were published by a group of scientists from the University of Wisconsin-Madison led by Bill Dove who is a professor of oncology and genetics with the McArdle Laboratory for Research and Carbone Cancer Center at UW-Madison. They published their discovery in the journal of Proceedings of the National Academy of Sciences.
According to Professor Dove this is a groundbreaking change in the cancer field. He commented on his results saying, “This study is the first peek at the possibility that there will be blood markers for a minimally-invasive procedure that can reduce over-diagnosis.”